AH
Highly rated in
14
conditions
Highly rated in
14
conditions
Check Dr. Arthur Y. Hung's experience treating your condition:
About Dr. Arthur Y. Hung

Arthur Hung is a Radiation Oncologist in Hillsboro, Oregon. Hung has been practicing medicine for over 26 years and is highly rated in 14 conditions, according to our data. His top areas of expertise are Prostate Cancer, Adult Soft Tissue Sarcoma, Familial Prostate Cancer, Prostatectomy, and Gamma Knife Radiosurgery. He is licensed to treat patients in Oregon. Hung is currently accepting new patients.

His clinical research consists of co-authoring 37 peer reviewed articles and participating in 8 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Arthur Y. Hung it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Arthur Y. Hung accepts the following insurance:

  •  Ambetter
  •  PacificSource
  •  Regence
  •  Moda Health
  •  Prominence Health
  •  BridgeSpan

Call to see if your plan is accepted.
Locations
299 Se 9th Ave, Hillsboro, OR 97123
Other Locations
3303 Sw Bond Ave, Portland, OR 97239
Background & Education
Graduate Institution
Ohio State University College Of Medicine, 1997
Specialties
Radiation Oncology
Licenses
Radiology in OR
Hospital Affiliations
OHSU Health Hillsboro Medical Center
Samaritan Pacific Communities Hospital
Portland VA Medical Center - Main Campus
Bay Area Hospital
OHSU Hospital - Portland
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

A Phase II Double-Blinded, Placebo-Controlled Trial of PROstate OligoMETastatic RadiotHErapy With or Without ANdrogen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG Promethean)
Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients With Post-ProstaTEctomy Biochemical Recurrence (INDICATE).
Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men With High-Risk PSA-Recurrent Prostate Cancer After Radical Prostatectomy
A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer
A Pilot Study Investigating ¹⁸F-FLT-PET as a Marker of Response to Preoperative Radiotherapy in Soft Tissue Sarcoma
Phase III Study of Preoperative vs Postoperative Intensity Modulated Radiation Therapy For Truncal/Extremity Soft Tissue Sarcoma
View 5 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors